Endoscopic resection techniques and ablative therapies for Barrett’s neoplasia

Table 1 Focal endoscopic mucosal resection in early Barrett’s neoplasia

Author	n	Complete regression of dysplasia/esophageal cancer (%)	Histology	Follow-up (mo)
Ell et al[43], 2000	64	86	HGD/EC	12 ± 8
May et al[44], 2002	28	79 (1001)	HGD/EC	34 ± 10
May et al[45], 2002	70	70 (981)	HGD/EC	34 ± 10
Behrens et al[48], 2005	14	93 (1001)	HGD	38
Peters et al[49], 2005	33	79 (1001)	Barrett’s esophagus	19
Conio et al[50], 2005	39	97.5	HGD/EC	35
Ell et al[53], 2007	100	88 (991)	Adenoca.	36
Pech et al[41], 2008	231	95.7	EC	61
Moss et al[54], 2010	35	77 (851)	HGD/EC	31

¹Results after second treatment. EC: Esophageal cancer; HGD: High grade dysplasia.